GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Price-to-Owner-Earnings

Biomaxima (WAR:BMX) Price-to-Owner-Earnings : 17.29 (As of Jun. 19, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Price-to-Owner-Earnings?

As of today (2024-06-19), Biomaxima's share price is zł16.60. Biomaxima's Owner Earnings per Share (TTM) ended in Mar. 2024 was zł0.96. It's Price-to-Owner-Earnings for today is 17.29.


The historical rank and industry rank for Biomaxima's Price-to-Owner-Earnings or its related term are showing as below:

WAR:BMX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 3.5   Med: 16.67   Max: 1323.53
Current: 16.86

During the past 13 years, the highest Price-to-Owner-Earnings of Biomaxima was 1323.53. The lowest was 3.50. And the median was 16.67.


WAR:BMX's Price-to-Owner-Earnings is ranked better than
66.67% of 69 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.48 vs WAR:BMX: 16.86

As of today (2024-06-19), Biomaxima's share price is zł16.60. Biomaxima's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.09. Therefore, Biomaxima's PE Ratio for today is 184.44.

As of today (2024-06-19), Biomaxima's share price is zł16.60. Biomaxima's EPS without NRI for the trailing twelve months (TTM) ended in was zł0.07. Therefore, Biomaxima's PE Ratio without NRI for today is 251.52.

During the past 13 years, Biomaxima's highest PE Ratio without NRI was 708.33. The lowest was 2.80. And the median was 14.50.


Biomaxima Price-to-Owner-Earnings Historical Data

The historical data trend for Biomaxima's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Price-to-Owner-Earnings Chart

Biomaxima Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.11 811.76 - 3.72 95.47

Biomaxima Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 95.47 12.73

Competitive Comparison of Biomaxima's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Biomaxima's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Biomaxima's Price-to-Owner-Earnings falls into.



Biomaxima Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Biomaxima's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=16.60/0.96
=17.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomaxima  (WAR:BMX) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Biomaxima Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Biomaxima's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima (WAR:BMX) Business Description

Traded in Other Exchanges
Address
5 Vetterow Street, Lublin, POL, 20-277
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines